Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Martin Widschwendter|Nature Reviews Clinical Oncology|2020Cited by 434
Validation of biomarkers of agingMahdi Moqri, Luigi Ferrucci, Chiara Herzog et al.|Nature Medicine|2024Cited by 299
Epigenome-based cancer risk prediction: rationale, opportunities and challengesMartin Widschwendter, Nora Pashayan, David Cibula et al.|Nature Reviews Clinical Oncology|2018Cited by 173
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolutionThomas E. Bartlett, Martin Widschwendter|Nature Communications|2016Cited by 74
Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarraysTatiana Nazarenko, Martin Widschwendter|Clinical Epigenetics|2024Cited by 8